DD150897A5 - Verfahren zur herstellung von neuen pyrazolo(1,5-c)chinazolinderivaten - Google Patents

Verfahren zur herstellung von neuen pyrazolo(1,5-c)chinazolinderivaten Download PDF

Info

Publication number
DD150897A5
DD150897A5 DD80221164A DD22116480A DD150897A5 DD 150897 A5 DD150897 A5 DD 150897A5 DD 80221164 A DD80221164 A DD 80221164A DD 22116480 A DD22116480 A DD 22116480A DD 150897 A5 DD150897 A5 DD 150897A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
group
quinazoline
meaning
alkyl
Prior art date
Application number
DD80221164A
Other languages
German (de)
English (en)
Inventor
Edit Berenyi
Enikoe Szirt
Peter Goeroeg
Lujza Petoecz
Ibolya Kosoczky
Agnes Kovacs
Gabriella Uermoes
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DD150897A5 publication Critical patent/DD150897A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD80221164A 1979-05-18 1980-05-16 Verfahren zur herstellung von neuen pyrazolo(1,5-c)chinazolinderivaten DD150897A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79EE2663A HU178523B (en) 1979-05-18 1979-05-18 Process for preparing new pyrazolo-quinazoline derivatives

Publications (1)

Publication Number Publication Date
DD150897A5 true DD150897A5 (de) 1981-09-23

Family

ID=10995850

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80221164A DD150897A5 (de) 1979-05-18 1980-05-16 Verfahren zur herstellung von neuen pyrazolo(1,5-c)chinazolinderivaten

Country Status (17)

Country Link
US (1) US4303660A (ru)
JP (1) JPS55154974A (ru)
AT (1) AT375941B (ru)
AU (1) AU528013B2 (ru)
BE (1) BE883204A (ru)
CH (1) CH646170A5 (ru)
CS (1) CS241026B2 (ru)
DD (1) DD150897A5 (ru)
DE (1) DE3019019A1 (ru)
ES (1) ES8105319A1 (ru)
FR (1) FR2456744A1 (ru)
GB (1) GB2051054B (ru)
GR (1) GR68462B (ru)
HU (1) HU178523B (ru)
IT (1) IT1149882B (ru)
NL (1) NL8002853A (ru)
SU (3) SU978731A3 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469868A (en) * 1982-05-24 1984-09-04 Warner-Lambert Company Alkylimidazo[1,2-c]pyrazolo[3,4-e]pyrimidines
DE3942357A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh 3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel
MXPA01008440A (es) * 1999-02-22 2002-04-24 Boehringer Ingelheim Pharma Derivados heterociclicos policiclos como agentes anti-inflamatorios..
GB2454549B (en) * 2007-09-25 2009-09-23 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
CN103130810B (zh) * 2013-03-11 2015-02-25 河南师范大学 一种吡唑并[1,5-c]喹唑啉类化合物的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313815A (en) * 1964-05-04 1967-04-11 Sterling Drug Inc 8-chloropyrazolo-[1, 5-c]quinazoline derivatives and methods of preparing same
US3531482A (en) * 1966-10-13 1970-09-29 Sandoz Ag Pyrazolo(1,5-c)quinazolines
US3897434A (en) * 1974-04-12 1975-07-29 Lilly Co Eli Pyrazolo{8 1,5-c{9 quinazolin-5(6H)-ones
US4076818A (en) * 1976-07-02 1978-02-28 E. R. Squibb & Sons, Inc. Pyrazolo [1,5-C]quinazoline derivatives and related compounds
US4112098A (en) * 1977-10-17 1978-09-05 E. R. Squibb & Sons, Inc. Pyrazolo[1,5-c]quinazoline derivatives and related compounds
US4110452A (en) * 1977-10-17 1978-08-29 E. R. Squibb & Sons, Inc. Pyrazolo (1,5-c) quinazoline derivatives and related compounds
US4198412A (en) * 1978-12-13 1980-04-15 E. R. Squibb & Sons, Inc. Pyrazolo [1,5-C] quinazoline derivatives and their use in treating allergic conditions

Also Published As

Publication number Publication date
GR68462B (ru) 1981-12-30
US4303660A (en) 1981-12-01
JPS55154974A (en) 1980-12-02
ATA262580A (de) 1984-02-15
GB2051054A (en) 1981-01-14
ES491608A0 (es) 1981-05-16
GB2051054B (en) 1983-05-18
DE3019019C2 (ru) 1988-12-01
CS241026B2 (en) 1986-03-13
IT8022111A0 (it) 1980-05-16
AT375941B (de) 1984-09-25
IT1149882B (it) 1986-12-10
SU1017171A3 (ru) 1983-05-07
HU178523B (en) 1982-05-28
ES8105319A1 (es) 1981-05-16
FR2456744A1 (fr) 1980-12-12
AU5848580A (en) 1980-11-20
DE3019019A1 (de) 1980-11-27
NL8002853A (nl) 1980-11-20
SU1015828A3 (ru) 1983-04-30
FR2456744B1 (ru) 1983-06-17
AU528013B2 (en) 1983-03-31
SU978731A3 (ru) 1982-11-30
JPH0227356B2 (ru) 1990-06-15
CH646170A5 (de) 1984-11-15
BE883204A (fr) 1980-11-10
CS340780A2 (en) 1985-06-13

Similar Documents

Publication Publication Date Title
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DE2027645A1 (de) Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE2125634A1 (de) Verfahren zur Herstellung von neuen Cycloheptenderivaten
EP0001115A2 (de) 2-Bromergosin und seine Säureadditionssalze, Verfahren zu deren Herstellung sowie deren Verwendung als Heilmittel
DE2118261A1 (de) Neue N-haltige Bicyclen, deren Säureadditionssalze sowie Verfahren zu deren Herstellung
DE3103372A1 (de) Neue indanyl-derivate, ihre herstellung und verwendung
DE2044172C3 (de) Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel
DE2313227A1 (de) Neue isoindolinderivate, ihre herstellung und die medizinischen zusammensetzungen, die sie enthalten
DD150897A5 (de) Verfahren zur herstellung von neuen pyrazolo(1,5-c)chinazolinderivaten
DE2463088C1 (de) Substituierte Thienylverbindungen,Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH618439A5 (ru)
EP0054873B1 (de) 3,4-Disubstituierte 1,2,5-Oxadiazol-2-oxide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
CH524612A (de) Verfahren zur Herstellung von neuen Imidazolderivaten
DE2242454A1 (de) 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DD154487A5 (de) Verfahren zur herstellung von 1-benzoxepin-5(2h)-on-derivaten
DE3630539A1 (de) Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten
DE2611118C2 (ru)
DE2034588C3 (de) 6,7-Dimethoxy-4-benzylisochinoline, Verfahren zu ihrer Herstellung und Arzneimittel
DE2351281B2 (de) Aminophenyl-äthanolamin-Derivate, deren Herstellung und Verwendung
EP0014996B1 (de) Heterocyclische spiroverknüpfte Amidine, ihre Stereoisomeren und optischen Isomeren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1468283C (ru)
EP0011255B1 (de) 1,2,3,4-Tetrahydro-6-oxo-2,8a-methano-6H-dibenz(c.e)azocine, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
DE2521519A1 (de) Substituierte 9,10-dihydroanthracen- 9,10-imine und heterocyclische (aza) analoge davon und verfahren zur herstellung dieser verbindungen
DE2251354A1 (de) Neue diuretica und mittel zur behandlung von hyperaldosteronismus
DE1445416C3 (de) N-substituierte 23-Polymethylenindole, ein Verfahren zu ihrer Herstellung und Arzneimittel

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee